We here found that LPHNs induced the growth of prostate cancer cells and that the activation of LPHNs was associated with phosphorylation of JAK2/STAT3, but not Akt or ERK1/2, as well as the increased expression of Bcl-2. Here, MAPK3 is linked to prostate carcinoma.